» Articles » PMID: 18294224

Prevalence and Risk Factors for Diabetic Neuropathy in an Urban South Indian Population: the Chennai Urban Rural Epidemiology Study (CURES-55)

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2008 Feb 26
PMID 18294224
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This study was conducted to determine the prevalence of, and risk factors for, diabetic neuropathy (DN) in south Indian Type 2 diabetic subjects.

Methods: Subjects were recruited from the Chennai Urban Rural Epidemiology Study, conducted on a representative cohort from Chennai city. A total of 1629 diabetic subjects were included, of whom 1291 were known to have diabetes (KD) subjects and 338 were randomly selected newly detected diabetic (NDD) subjects. Neuropathy was diagnosed if vibratory perception threshold at the great toe, measured by biothesiometry, exceeded mean + 2 sd of a healthy non-diabetic study population aged 20-45 years (cut point > or = 20 V).

Results: The overall prevalence of DN was 26.1% (age-adjusted 13.1%) with no significant difference in gender. The prevalence of neuropathy was significantly higher in KD subjects compared with NDD subjects (27.8 vs. 19.5%, P = 0.002). The prevalence of diabetic retinopathy (24.1 vs. 15.3%, P < 0.0001) and hypertension (51.1 vs. 40.0%, P < 0.0001) were higher in those with neuropathy compared with those without. The odds ratio for neuropathy in subjects with duration of diabetes > 15 years compared with < or = 5 years was 5.7 (95% confidence interval: 3.52-9.08, P < 0.0001). Regression analysis showed age (P < 0.0001), glycated haemoglobin (P = 0.001) and duration of diabetes (P = 0.045) to be significantly associated with neuropathy.

Conclusions: This cross-sectional population-based study shows that, among urban south Indian Type 2 diabetic subjects, the prevalence of DN is 26.1% and that DN is significantly associated with age, glycated haemoglobin and duration of diabetes.

Citing Articles

Development of risk prediction scores for diabetic peripheral neuropathy patients.

Laxmi M, Prabhakar O J Neurosci Rural Pract. 2023; 14(4):667-670.

PMID: 38059227 PMC: 10696327. DOI: 10.25259/JNRP_151_2023.


Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus.

Reddy Mallimala P, Shah K, Mirchandani M, Sharma K Cureus. 2023; 15(8):e44348.

PMID: 37779807 PMC: 10539158. DOI: 10.7759/cureus.44348.


Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.

Sharma K N S, Kumar H A J Foot Ankle Res. 2023; 16(1):65.

PMID: 37770911 PMC: 10537102. DOI: 10.1186/s13047-023-00667-3.


The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial).

Das A, Kalra S, Joshi S, Mithal A, Prasanna Kumar K, Unnikrishnan A Endocrinol Diabetes Metab. 2023; 6(5):e422.

PMID: 37392036 PMC: 10495555. DOI: 10.1002/edm2.422.


Sex-Based Differences in Clinical Profile and Complications among Individuals with Type 2 Diabetes Seen at a Private Tertiary Diabetes Care Centre in India.

Pradeepa R, Shreya L, Anjana R, Jebarani S, Venkatesan U, Kamal Raj N Healthcare (Basel). 2023; 11(11).

PMID: 37297774 PMC: 10252405. DOI: 10.3390/healthcare11111634.